XCYTRIN™ (motexafin gadolinium) and whole brain radiation for patients with brain metastases: Lead-in phase to randomized trial - final results Article

Mehta, MP, Meyers, CA, Curran, WJ et al. (2000). XCYTRIN™ (motexafin gadolinium) and whole brain radiation for patients with brain metastases: Lead-in phase to randomized trial - final results . INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 48(3), 204. 10.1016/s0360-3016(00)80201-1

cited authors

  • Mehta, MP; Meyers, CA; Curran, WJ; Schultz, CJ; Ford, JM; Roa, WH; Leibenhaut, M; Cmelak, AJ; Rao, A; Timmerman, RD; Gaspar, L; Phan, SC; Eber, D; Renschler, MF

authors

publication date

  • January 1, 2000

keywords

  • 32 Biomedical and Clinical Sciences
  • 3211 Oncology and Carcinogenesis
  • Brain Cancer
  • Brain Disorders
  • Cancer
  • Clinical Research
  • Clinical Trials and Supportive Activities
  • Neurosciences
  • Radiation Oncology
  • Rare Diseases

Digital Object Identifier (DOI)

publisher

  • Elsevier

start page

  • 204

volume

  • 48

issue

  • 3